Pain Control and Anxiolysis After Subarachnoid Hemorrhage Using Immersive Virtual Reality: A Case Report.

headache pain management subarachnoid hemorrhage virtual reality

Journal

The Neurohospitalist
ISSN: 1941-8744
Titre abrégé: Neurohospitalist
Pays: United States
ID NLM: 101558199

Informations de publication

Date de publication:
Jul 2022
Historique:
entrez: 27 6 2022
pubmed: 28 6 2022
medline: 28 6 2022
Statut: ppublish

Résumé

Debilitating headache persists after acute aneurysmal subarachnoid hemorrhage (SAH). Despite high prevalence, little is known regarding optimal treatment strategies for SAH-related headache. Nonpharmacologic adjunctive therapies are emerging as tools to help treat pain and limit opioid exposure in the hospital. Virtual reality (VR) is an immersive audiovisual experience that has been shown to reduce pain perception in other patient populations. The role of VR in acute brain injury is unknown. Here we report a patient with SAH who suffered from persistent headache during her hospitalization despite escalation of analgesic pharmacotherapy. A trial of VR was used as an adjunct to medication over four days. The patient reported subjective improvement in pain and anxiety. VR may provide additional analgesia and anxiolysis over pharmacologic measures alone and warrants further study in patients with acute brain injury.

Identifiants

pubmed: 35755230
doi: 10.1177/19418744221099412
pii: 10.1177_19418744221099412
pmc: PMC9214923
doi:

Types de publication

Case Reports

Langues

eng

Pagination

563-566

Informations de copyright

© The Author(s) 2022.

Déclaration de conflit d'intérêts

Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Références

Curr Opin Crit Care. 2016 Oct;22(5):506-12
pubmed: 27490213
Ann Behav Med. 2011 Apr;41(2):183-91
pubmed: 21264690
Neurocrit Care. 2021 Jun;34(3):760-768
pubmed: 32851604
Neuroreport. 2004 Jun 7;15(8):1245-8
pubmed: 15167542
Innov Clin Neurosci. 2017 Feb 01;14(1-2):14-21
pubmed: 28386517
Pain Med. 2013 May;14(5):621-7
pubmed: 23659372
Lancet. 2019 Apr 13;393(10180):1558-1568
pubmed: 30983591
Neurocrit Care. 2019 Oct;31(2):434-438
pubmed: 31037638
Headache. 2016 Nov;56(10):1617-1625
pubmed: 27704534
Neurology. 2021 May 11;96(19):e2355-e2362
pubmed: 33766993
Cerebrovasc Dis. 2013;35(2):93-112
pubmed: 23406828
Neurocrit Care. 2013 Dec;19(3):306-10
pubmed: 24037248
Anesth Analg. 2007 Dec;105(6):1776-83, table of contents
pubmed: 18042882
Acta Neurochir (Wien). 2020 Apr;162(4):893-903
pubmed: 32016589
Clin Pharmacol Ther. 2019 Dec;106(6):1246-1252
pubmed: 31350784

Auteurs

Adam Kardon (A)

Department of Neurology, University of Maryland School of Medicine, Baltimore, MD, USA.

Robert S Murray (RS)

Program in Trauma, R Adams Cowley Shock Trauma Center, Baltimore, MD, USA.

Mazhar Khalid (M)

Department of Neurology, University of Maryland School of Medicine, Baltimore, MD, USA.

Luana Colloca (L)

Department of Pain and Translational Symptom Science, University of Maryland School of Nursing, Baltimore, MD, USA.

J Marc Simard (JM)

Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, MD, USA.

Neeraj Badjatia (N)

Department of Neurology, University of Maryland School of Medicine, Baltimore, MD, USA.
Program in Trauma, R Adams Cowley Shock Trauma Center, Baltimore, MD, USA.

Sarah B Murthi (SB)

Program in Trauma, R Adams Cowley Shock Trauma Center, Baltimore, MD, USA.
Department of Surgery, University of Maryland School of Medicine, Baltimore, MD, USA.

Nicholas A Morris (NA)

Department of Neurology, University of Maryland School of Medicine, Baltimore, MD, USA.
Program in Trauma, R Adams Cowley Shock Trauma Center, Baltimore, MD, USA.

Classifications MeSH